Publication | Open Access

Moxifloxacin plus rifampin as an alternative for levofloxacin plus rifampin in the treatment of a prosthetic joint infection with Staphylococcus aureus

Health SciencesAntibioticsHealthcare-associated InfectionStaphylococcus AureusAntimicrobial ResistanceProsthetic Joint InfectionsProsthetic Joint InfectionAntimicrobial ChemotherapyInfection ControlAntimicrobial CompoundMedicineClinical MicrobiologyOrthopaedic SurgeryDrug Resistance